Free Trial

Stevanato Group (NYSE:STVN) Stock Price Up 7.6% - Here's Why

Stevanato Group logo with Medical background

Key Points

  • Stevanato Group's stock price increased by 7.6%, reaching as high as €25.88 ($30.09) during trading, with a significant volume of 612,271 shares exchanged, highlighting strong investor interest.
  • Analysts maintain a "Moderate Buy" consensus rating with one Strong Buy, three Buy, and two Hold ratings, indicating positive sentiment toward the stock's performance.
  • Recent institutional investments included significant new positions by firms such as Whittier Trust Co. and Twin Tree Management, with the State of Wyoming increasing its holdings by over 39,000%.
  • Interested in Stevanato Group? Here are five stocks we like better.

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report)'s stock price traded up 7.6% on Wednesday . The stock traded as high as €25.88 ($30.45) and last traded at €24.38 ($28.68). 612,271 shares changed hands during trading, an increase of 81% from the average session volume of 338,086 shares. The stock had previously closed at €22.65 ($26.65).

Analysts Set New Price Targets

Separately, William Blair restated an "outperform" rating on shares of Stevanato Group in a research report on Monday, June 30th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy".

Read Our Latest Report on Stevanato Group

Stevanato Group Stock Performance

The firm's 50-day moving average is €24.09 and its 200 day moving average is €22.69. The stock has a market cap of $7.73 billion, a PE ratio of 47.28, a P/E/G ratio of 2.28 and a beta of 0.55. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.22 and a current ratio of 1.79.

Hedge Funds Weigh In On Stevanato Group

Several institutional investors have recently bought and sold shares of STVN. Invesco Ltd. acquired a new position in Stevanato Group in the 1st quarter valued at $19,072,000. Champlain Investment Partners LLC acquired a new position in Stevanato Group in the 1st quarter valued at $15,741,000. Ranger Investment Management L.P. grew its stake in shares of Stevanato Group by 125.6% during the 2nd quarter. Ranger Investment Management L.P. now owns 1,321,030 shares of the company's stock worth $32,273,000 after purchasing an additional 735,417 shares during the period. MetLife Investment Management LLC acquired a new position in shares of Stevanato Group during the 1st quarter worth $12,944,000. Finally, Loomis Sayles & Co. L P acquired a new position in shares of Stevanato Group during the 2nd quarter worth $13,729,000.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Read More

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.